The DOI matches its Crossref record; 352 of the 357 references it cites were found in a registry or an index.
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Open accessAbstract
Anhedonia is a core symptom of major depressive disorder (MDD), the neurobiological mechanisms of which remain poorly understood. Despite decades of speculation regarding the role of dopamine (DA) in anhedonic symptoms, empirical evidence has remained elusive, with frequent reports of contradictory findings. In the present review, we argue that this has resulted from an underspecified definition of anhedonia, which has failed to dissociate between consummatory and motivational aspects of reward behavior. Given substantial preclinical evidence that DA is involved primarily in motivational aspects of reward, we suggest that a refined definition of anhedonia that distinguishes between deficits in pleasure and motivation is essential for the purposes of identifying its neurobiological substrates. Moreover, bridging the gap between preclinical and clinical models of anhedonia may require moving away from the conceptualization of anhedonia as a steady-state, mood-like phenomena. Consequently, we introduce the term "decisional anhedonia" to address the influence of anhedonia on reward decision-making. These proposed modifications to the theoretical definition of anhedonia have implications for research, assessment and treatment of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Anhedonia and impaired reward circuit pathways are associated with a poorer prognosis and suboptimal treatment response (Buckner et al., 2008;Uher et al., 2012;Treadway and Zald, 2011).”
From Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment (2021) · cites this paper as Treadway and Zald, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“studies of the neurobiology of reward processing have highlighted the variety of distinct pathways involved in its different aspects resulting in the recognition of separate subtypes of anhedonia, including consummatory, anticipatory, motivational and decisional [20,21].”
From Prefrontal cortex and depression (2022) · cites this paper as [20]
Experimental — accuracy not yet measuredIn the citing paper
“Anhedonia is a broad construct that includes deficits in anticipation of, motivation toward, and responsiveness to reward, as well as deficits in reward learning (ability to recall and make decisions based on past rewarding experiences) (Treadway and Zald, 2011) and is estimated to be 46% heritable in studies of monozygotic twins (Bogdan and Pizzagalli, 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Treadway and Zald, 2011
In the citing paper
“hyposensitivity to reward and hypersensitivity to punishment have been a consistent finding in depression”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Treadway and Zald 2011
In the citing paper
“Dysregulation of dopamine release in motivating responses to rewarding and aversive stimuli, as well as cognitive demand, is a plausible mechanistic cause that can explain a range of depression symptoms [24][25][26][27][28][29].”
From Plasticity of synapses and reward circuit function in the genesis and treatment of depression (2023) · cites this paper as [25]
In the citing paper
“Particularly relevant in the present context are previous reports [290,296,297] that although both DA and non-DA agents can be used to effectively treat mood disorders, DA agents generally have superior effects on symptoms of anhedonia, specifically when compared with non-DA agents [19,298-300].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [19]
In the citing paper
“The mesolimbic DA system represents only one component of a very complex and integrated set of circuits, and although DA is clearly a crucial neurotransmitter in the reward-processing system, non-DA systems clearly also modulate reward responsibility [19,735].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [19]
In the citing paper
“Additionally, multiple non-DA compounds have shown efficacy in improving reward responses, such as agents that affect glutamate circuits involved in regulating monoamine systems [19].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [19]
In the citing paper
“However, recent studies suggest that many patients with schizophrenia or Parkinson’s, and possibly some with major depression, are not actually anhedonic after all: they report normal sensory pleasure ratings of ice cream or other sensory reward in the moment, even though they attach little value to any sensory, social or other pleasant reward in life.”
From Evolving Concepts of Emotion and Motivation (2018) · cites this paper as Treadway and Zald, 2011
In the citing paper
“Some investigators therefore have suggested their deficit really reflects a selective loss of incentive motivation or ‘wanting,’ rather than loss of pleasure ‘liking’ (Sienkiewicz-Jarosz et al., 2005; Dowd and Barch, 2010; Treadway and Zald, 2011; Barch et al., 2014).”
From Evolving Concepts of Emotion and Motivation (2018) · cites this paper as Treadway and Zald, 2011
In the citing paper
“Anhedonia typically does not respond to first-line pharmacotherapies [5, 7, 8]”
From Chronic unpredictable stress induces depression-related behaviors by suppressing AgRP neuron activity (2021) · cites this paper as [5]
In the citing paper
“co-morbid traits, such as depression, anxiety, or inattention/hyperactivity, are often associated with ASD [212], and are known to affect general reward processing [213,214] and intervention response [215].”
From Social “wanting” dysfunction in autism: neurobiological underpinnings and treatment implications (2012) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–352 of 352
Dopamine D2 receptors in depression measured with single photon emission computed tomography
D'haenen, H. A., & Bossuyt, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91202-5 · Cited by 189
The dopamine synapse and the notion of ‘pleasure centers’ in the brain
Wise, R. A. (1980) · Trends in Neurosciences · doi:10.1016/0166-2236(80)90035-1 · Cited by 186
Why are depression and anxiety correlated? A test of the tripartite model.
Burns, D. D., & Eidelson, R. J. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.66.3.461 · Cited by 182
Reduced caudate gray matter volume in women with major depressive disorder
Kim, M. J., Hamilton, J. P., & Gotlib, I. H. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.12.020 · Cited by 180
Learned, S. M., Bergström, M., Savitcheva, I., Ascher, J. A., Schmith, V. D., & Långström, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01834-6 · Cited by 179
Berlin, I., Givry-Steiner, L., Lecrubier, Y., & Puech, A. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)80048-5 · Cited by 178
Zangen, A., Nakash, R., Overstreet, D. H., & Yadid, G. (2001) · Psychopharmacology · doi:10.1007/s002130100746 · Cited by 177
Richards, F. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90780-4 · Cited by 177
Cerebral Monoamines and Depression
van Praag, H. M. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360053007 · Cited by 176
Unipolar depression does not moderate responses to the Sweet Taste Test
Dichter, G. S., Smoski, M. J., Kampov-Polevoy, A. B., Gallop, R., & Garbutt, J. C. (2010) · Depression and Anxiety · doi:10.1002/da.20690 · Cited by 175
Cousins, M. S., & Salamone, J. D. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90460-x · Cited by 174
Alterations in reward-related decision making in boys with recent and future depression
Forbes, E. E., Shaw, D. S., & Dahl, R. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.026 · Cited by 173
Zald, D. H., & Kim, S. W. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.2.125 · Cited by 172
Self-citationReward fails to alter response bias in depression.
Henriques, J. B., Glowacki, J. M., & Davidson, R. J. (1994) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.103.3.460 · Cited by 172
Striatal dopamine transporter density in major depression
Laasonen-Balk, T., Kuikka, J. T., Viinam�ki, H., Husso, M., Lehtonen, J., & Tiihonen, J. (1999) · Psychopharmacology · doi:10.1007/s002130051005 · Cited by 171
Clinical and psychometric correlates of dopamine D2 binding in depression
SHAH, P. J., OGILVIE, A. D., GOODWIN, G. M., & EBMEIER, K. P. (1997) · Psychological Medicine · doi:10.1017/s0033291797005382 · Cited by 170
Lemke, M. R., Brecht, H. M., Koester, J., Kraus, P. H., & Reichmann, H. (2005) · Journal of Neuropsychiatry · doi:10.1176/jnp.17.2.214 · Cited by 166
Dopamine D2-Like Receptors and the Antidepressant Response
Gershon, A. A., Vishne, T. H., & Grunhaus, L. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.031 · Cited by 166
Sloan (1997) · doi:10.1016/s0165-0327(97)00097-9 · Cited by 163
CSF monoamine metabolites in depression and schizophrenia
Berger, P. A., Faull, K. F., Kilkowski, J., Anderson, P. J., KRAEMER, H. C., Davis, K. L., & Barchas, J. D. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.2.174 · Cited by 163
Neural response to pleasant stimuli in anhedonia: an fMRI study
Mitterschiffthaler, M. T., Kumari, V., Malhi, G. S., Brown, R. G., Giampietro, V. P., Brammer, M. J., Suckling, J., Poon, L., Simmons, A., Andrew, C., et al. (2003) · NeuroReport · doi:10.1097/00001756-200302100-00003 · Cited by 162
Kugaya, A., Seneca, N. M., Snyder, P. J., Williams, S. A., Malison, R. T., Baldwin, R. M., Seibyl, J. P., & Innis, R. B. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300036 · Cited by 161
Dynamics of the dopaminergic system as a key component to the understanding of depression
Yadid, G., & Friedman, A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00913-8 · Cited by 160
Meyer, J. H., McNeely, H. E., Sagrati, S., Boovariwala, A., Martin, K., Verhoeff, N. P. L. G., Wilson, A. A., & Houle, S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1594 · Cited by 160
Bodkin, J. A., Lasser, R. A., Wines, J. D., Gardner, D. M., & Baldessarini, R. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0401 · Cited by 159
Coryell, W., Nopoulos, P., Drevets, W., Wilson, T., & Andreasen, N. C. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1706 · Cited by 159
McFarland, B. R., & Klein, D. N. (2009) · Depression and Anxiety · doi:10.1002/da.20513 · Cited by 157
Trémeau, F., Malaspina, D., Duval, F., Corrêa, H., Hager-Budny, M., Coin-Bariou, L., Macher, J.-P., & Gorman, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.92 · Cited by 157
Psychostimulants for depression
Candy, B., Jones, L., Williams, R., Tookman, A., & King, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006722.pub2 · Cited by 156
Taste-related activity in the human dorsolateral prefrontal cortex
Kringelbach, M. L., de Araújo, I. E., & Rolls, E. T. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.09.063 · Cited by 156
A ‘crash’ course on psychostimulant withdrawal as a model of depression
Barr, A. M., Markou, A., & Phillips, A. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02086-2 · Cited by 156
The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta-analysis
López‐León, S., Croes, E. A., Sayed‐Tabatabaei, F. A., Claes, S. J., Broeckhoven, C. V., & van Duijn, C. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.030 · Cited by 156
Salamone, J. D. (1996) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(95)00125-5 · Cited by 156
Bupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly
Weihs, K. L., Settle, E. C., Batey, S. R., Houser, T. L., Donahue, R. M. J., & Ascher, J. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0309 · Cited by 150
Smaller Cingulate Volumes in Unipolar Depressed Patients
Caetano, S. C., Kaur, S., Brambilla, P., Nicoletti, M., Hatch, J. P., Sassi, R. B., Mallinger, A. G., Keshavan, M. S., Kupfer, D. J., Frank, E., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.011 · Cited by 150
Neural correlates of reward processing in adolescents with a history of inhibited temperament
Bar-Haim, Y., Fox, N. A., Benson, B., Guyer, A. E., Williams, A., Nelson, E. E., Perez-Edgar, K., Pine, D. S., & Ernst, M. (2009) · Psychological Science · doi:10.1111/j.1467-9280.2009.02401.x · Cited by 150
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients
Kavoussi, R. J., Segraves, R. T., Hughes, A. R., Ascher, J. A., & Johnston, J. A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1204 · Cited by 149
Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments
Willner, P. (1983) · Brain Research Reviews · doi:10.1016/0165-0173(83)90007-3 · Cited by 149
Schweimer, J. V., & Hauber, W. (2005) · Learning & Memory · doi:10.1101/lm.90605 · Cited by 149
Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.
Volkow, N. D., Wang, G. J., Fowler, J. S., Gatley, S. J., Ding, Y. S., Logan, J., Dewey, S. L., Hitzemann, R., & Lieberman, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10388 · Cited by 149
Peciña, S. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00044-0 · Cited by 148
Bupropion occupancy of the dopamine transporter is low during clinical treatment
Meyer, J. H., Goulding, V. S., Wilson, A. A., Hussey, D. F., Christensen, B. K., & Houle, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1166-3 · Cited by 147
Cordeira, J., Frank, L., Sena‐Esteves, M., Pothos, E. N., & Rios, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5768-09.2010 · Cited by 147
Bruijnzeel, A. W., & Markou, A. (2003) · Synapse · doi:10.1002/syn.10242 · Cited by 146
Early adverse events, HPA activity and rostral anterior cingulate volume in MDD
Treadway, M. T., Grant, M. M., Ding, Z., Hollon, S. D., Gore, J. C., & Shelton, R. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004887 · Cited by 142
Self-citationCoffman, S. J., Martell, C. R., Dimidjian, S., Gallop, R., & Hollon, S. D. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.4.531 · Cited by 141
Dopamine modulates neural networks involved in effort-based decision-making
Assadi, S. M., Yücel, M., & Pantelis, C. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.010 · Cited by 140
Gehricke, J.-G., & Shapiro, D. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00168-2 · Cited by 140
Bupropion and amitriptyline in the treatment of depressed patients.
Lader, M. (1983) · PubMed · Cited by 140
Assessing the effects of bupropion SR on mood dimensions of depression
Tomarken, A. J., Dichter, G. S., Freid, C., Addington, S., & Shelton, R. C. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00306-3 · Cited by 139
Lesions of Nucleus Accumbens Disrupt Learning about Aversive Outcomes
Schoenbaum, G. M., & Setlow, B. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09833.2003 · Cited by 137
Zald, D. H., & Kim, S. W. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.3.249 · Cited by 136
Self-citationFacial expression of emotions in borderline personality disorder and depression
Renneberg, B., Heyn, K., Gebhard, R., & Bachmann, S. (2005) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2005.05.002 · Cited by 136
Stahl, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00957-4 · Cited by 134
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01089-7 · Cited by 133
Reward-Spatial View Representations and Learning in the Primate Hippocampus
Rolls, E. T., & Xiang, J.-Z. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1481-05.2005 · Cited by 133
Coleman, C. C., Cunningham, L. A., Foster, V. J., Batey, S. R., Donahue, R. M. J., Houser, T. L., & Ascher, J. A. (1999) · Annals of Clinical Psychiatry · doi:10.1023/a:1022309428886 · Cited by 131
Nucleus accumbens dopamine and work requirements on interval schedules
Correa, M., Carlson, B. B., Wisniecki, A., & Salamone, J. D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00292-9 · Cited by 130
Dopamine Enhances Expectation of Pleasure in Humans
Sharot, T., Shiner, T., Brown, A. C., Fan, J., & Dolan, R. J. (2009) · Current Biology · doi:10.1016/j.cub.2009.10.025 · Cited by 129
Walton, M. E., Groves, J., Jennings, K. A., Croxson, P. L., Sharp, T., Rushworth, M. F. S., & Bannerman, D. M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06726.x · Cited by 129
Piazza, P. V., Barrot, M., Rougé‐Pont, F., Marinelli, M., Maccari, S., Abrous, D. N., Simon, H., & Moal, M. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15445 · Cited by 129
Cryan, J. F., Dalvi, A., Jin, S., Hirsch, B. R., Lucki, I., & THOMAS, S. A. (2001) · PubMed · Cited by 129
The role of β-endorphin in the pathophysiology of major depression
Hegadoren, K., O'Donnell, T., Lanius, R. A., Coupland, N. J., & Lacaze-Masmonteil, N. (2009) · Neuropeptides · doi:10.1016/j.npep.2009.06.004 · Cited by 128
Klimke, A. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00009-8 · Cited by 126
Regional Brain Metabolic Correlates of α-Methylparatyrosine–Induced Depressive Symptoms
Bremner, J. D., Vythilingam, M., Ng, C. K., Vermetten, E. H. G. J. M., Nazeer, A., Oren, D. A., Berman, R., & Charney, D. S. (2003) · JAMA · doi:10.1001/jama.289.23.3125 · Cited by 124
Cannon, D. M., Klaver, J. M., Peck, S. A., Rallis, D., Erickson, K., & Drevets, W. C. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.194 · Cited by 122
Anhedonia After a Selective Bilateral Lesion of the Globus Pallidus
Miller, J. M., Vorel, S. R., Tranguch, A. J., Kenny, E. T., Mazzoni, P., van Gorp, W. G., & Kleber, H. D. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.786 · Cited by 120
Early‐ and late‐onset startle modulation in unipolar depression
Dichter, G. S., Tomarken, A. J., Shelton, R. C., & Sutton, S. K. (2004) · Psychophysiology · doi:10.1111/j.1469-8986.00162.x · Cited by 113
Schoenbaum, G., Setlow, B., & Ramus, S. J. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.013 · Cited by 113
Dopamine and depression: A review of recent evidence. II. Theoretical approaches
Willner, P. (1983) · Brain Research Reviews · doi:10.1016/0165-0173(83)90006-1 · Cited by 112
Psychostimulant withdrawal as an inducing condition in animal models of depression
Barr, A. M., & Markou, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.012 · Cited by 112
Can Recovery From Depression Be Achieved?
Shelton, R. C., & Tomarken, A. J. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.11.1469 · Cited by 111
Short-term antidepressant treatment modulates amygdala response to happy faces
Norbury, R., Taylor, M. J., Selvaraj, S., Murphy, S. E., Harmer, C. J., & Cowen, P. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1597-1 · Cited by 109
Dopamine transporter binding in depressed patients with anhedonia
Sarchiapone, M., Carli, V., Camardese, G., Cuomo, C., Giuda, D. D., Calcagni, M. L., Focacci, C., & Risio, S. D. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.03.001 · Cited by 108
Comparison of Bupropion and Trazodone for the Treatment of Major Depression
Weisler, R. H., Johnston, J., Lineberry, C. G., Samara, B., Branconnier, R. J., & Billow, A. A. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199406000-00004 · Cited by 107
Zald, D. H. (2006) · Cited by 106
Self-citationAnhedonia and Affect Deficit States
Clark, D., & FAWCETT, J. A. (1987) · Medical Entomology and Zoology · Cited by 105
Delay discounting and future-directed thinking in anhedonic individuals
Lempert, K. M., & Pizzagalli, D. A. (2010) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2010.02.003 · Cited by 105
Coleman, C., Cunningham, L., Foster, V., et al. (1999) · Annals of Clinical Psychiatry · doi:10.3109/10401239909147072 · Cited by 105
Calculating the Cost of Acting in Frontal Cortex
Walton, M. E., Rudebeck, P. H., Bannerman, D. M., & Rushworth, M. F. S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1390.009 · Cited by 102
Wagner, G., Koch, K., Schachtzabel, C., Reichenbach, J. R., Sauer, H., & Schlösser, R. G. M. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0820 · Cited by 101
Schweimer, J. V., Saft, S., & Hauber, W. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.6.1687 · Cited by 101
Mingote, S., Weber, S. M., Ishiwari, K., Correa, M., & Salamone, J. D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03972.x · Cited by 101
Takahashi, T., Oono, H., Inoue, T., Boku, S., Kako, Y., Kitaichi, Y., Kusumi, I., Masui, T., Nakagawa, S., Suzuki, K., et al. (2011) · PubMed · doi:10.48550/arxiv.1111.6493 · Cited by 99
Categorical and dimensional reports of experienced affect to emotion-inducing pictures in depression
Dunn, B. D., Dalgleish, T., Lawrence, A. D., Cusack, R., & Ogilvie, A. D. (2004) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.113.4.654 · Cited by 99
Cryan, J. F., Dalvi, A., Jin, S., Hirsch, B. R., Lucki, I., & THOMAS, S. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29424-6 · Cited by 99
Where’s the fun in that? Broadening the focus on reward function in depression
Forbes, E. E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.001 · Cited by 98
Anterior cingulate volumes in never-treated patients with major depressive disorder
Yucel, K., McKinnon, M. C., Chahal, R., Taylor, V. H., Macdonald, K., Joffe, R., & MacQueen, G. M. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.40 · Cited by 96
Bromocriptine and imipramine in endogenous depression
Wæhrens, J., & Gerlach, J. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90044-6 · Cited by 91
Matsuo, K., Rosenberg, D. R., Easter, P. C., MacMaster, F. P., Chen, H.-H., Nicoletti, M., Caetano, S. C., Hatch, J. P., & Soares, J. C. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0026 · Cited by 89
Effects of Naltrexone on the Subjective Response to Amphetamine in Healthy Volunteers
Jayaram‐Lindström, N., Wennberg, P., Hurd, Y. L., & Franck, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144893.29987.e5 · Cited by 88
Animal models and treatments for addiction and depression co-morbidity
Paterson, N. E., & Markou, A. (2007) · Neurotoxicity Research · doi:10.1007/bf03033479 · Cited by 85
Amsterdam, J. D., & Newberg, A. B. (2007) · Neuropsychobiology · doi:10.1159/000106476 · Cited by 84
Pickar, D., Davis, G. C., Schulz, S. C., Extein, I., Wagner, R., Naber, D., Gold, P. W., van Kammen, D. P., Goodwin, F. K., Wyatt, R. J., et al. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.2.160 · Cited by 84
μ-Opioid receptors and limbic responses to aversive emotional stimuli
Liberzon, I., Zubieta, J. K., Fig, L. M., Phan, K. L., Koeppe, R. A., & Taylor, S. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102174799 · Cited by 83
Nucleus Accumbens Dopamine Depletions and Time-Constrained Progressive Ratio Performance
Hamill, S., Trevitt, J. T., Nowend, K. L., Carlson, B. B., & Salamone, J. D. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00092-1 · Cited by 82
Paterson, N. E., Balfour, D. J. K., & Markou, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05546.x · Cited by 80
Beyond DSM : Seeking a Brain-Based Classification of Mental Illness
Miller, G. (2010) · Science · doi:10.1126/science.327.5972.1437 · Cited by 77
Diagnosing Major Depressive Disorder VIII: Are Some Symptoms Better Than Others?
McGlinchey, J. B., Zimmerman, M., Young, D., & Chelminski, I. (2006) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000240222.75201.aa · Cited by 77
PET Studies of Presynaptic Monoamine Metabolism in Depressed Patients and Healthy Volunteers
Ågren, H., & Reibring, L. (1994) · Pharmacopsychiatry · doi:10.1055/s-2007-1014265 · Cited by 74
Emerging targets for antidepressant therapies
Rakofsky, J. J., Holtzheimer, P. E., & Nemeroff, C. B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.617 · Cited by 73
Ropinirole in treatment-resistant depression: a 16-week pilot study
Cassano, P., Lattanzi, L., Fava, M., Navari, S., Battistini, G., Abelli, M., & Cassano, G. B. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000612 · Cited by 73
Bupropion increases striatal vesicular monoamine transport
Rau, K. S., Birdsall, E., Hanson, J. E., Johnson‐Davis, K. L., Carroll, F. I., Wilkins, D. G., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.05.004 · Cited by 72
Decreased perceptual sensitivity to emotion-evoking stimuli in depression
Wexler, B. E., Levenson, L. N., Warrenburg, S., & Price, L. H. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90032-9 · Cited by 71
Hirvonen, J., Karlsson, H., Kajander, J., Markkula, J., Rasi-Hakala, H., Någren, K., Salminen, J. K., & Hietala, J. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1088-9 · Cited by 70
Koerts, J., Leenders, K. L., Koning, M. D., Portman, A. T., & van Beilen, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05580.x · Cited by 70
Yang, Y. K., Yeh, T. L., Yao, W. J., Lee, I. H., Chen, P. S., Chiu, N.-T., & Lu, R. B. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.08.008 · Cited by 69
Kazès, M., Danion, J., Grangé, D., Pradignac, A., Simon, C., Burrus-Mehl, F., Schlienger, J.-L., & Singer, L. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90080-9 · Cited by 66
Wagner, G., Koch, K., Schachtzabel, C., Peikert, G., Sauer, H., & Schlösser, R. G. M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.12.054 · Cited by 63
Long-Term Pharmacotherapy for Post-Traumatic Stress Disorder
Davis, L. L., Frazier, E. C., Williford, R. B., & Newell, J. M. (2006) · CNS Drugs · doi:10.2165/00023210-200620060-00003 · Cited by 62
Vale, S., Espejel, M. A., & Dominguez, J. C. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90153-x · Cited by 61
Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder
Dikeos, D. G., Papadimitriou, G. N., Avramopoulos, D., Karadima, G., Daskalopoulou, E. G., Souery, D., Mendlewicz, J., Vassilopoulos, D., & STEFANIS, C. N. (1999) · Psychiatric Genetics · doi:10.1097/00041444-199912000-00005 · Cited by 59
Walton, M. E., Croxson, P. L., Rushworth, M. F. S., & Bannerman, D. M. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.1.323 · Cited by 59
Methylphenidate augmentation of citalopram in elderly depressed patients.
Lavretsky, H., & Kumar, A. (2001) · The American journal of geriatric psychiatry · doi:10.1097/00019442-200108000-00015 · Cited by 58
Invernizzi, R. W., Pozzi, L., Garattini, S. K., & SAMANIN, R. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90171-k · Cited by 57
An open study of methylphenidate in bipolar depression
El‐Mallakh, R. S. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020108.x · Cited by 57
Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder
Yücel, K., MKinnon, M., Chahal, R., Taylor, V. H., Macdonald, K., Joffe, R. T., & MacQUEEN, G. M. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.07.013 · Cited by 53
Kaczmarek, H. J., & Kiefer, S. W. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00182-9 · Cited by 52
Posed facial expressions of emotion in schizophrenia and depression
Berenbaum, H. (1992) · Psychological Medicine · doi:10.1017/s0033291700038502 · Cited by 52
The effects of depression on the emotional responses of Spanish-speaking Latinas.
Tsai, J. L., Pole, N., LEVENSON, R. W., & Muñoz, R. F. (2003) · Cultural Diversity & Ethnic Minority Psychology · doi:10.1037/1099-9809.9.1.49 · Cited by 50
Reynolds, C. F., Frank, E., Dew, M. A., Houck, P. R., Miller, M., Mazumdar, S., Perel, J. M., & Kupfer, D. J. (1999) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199902000-00009 · Cited by 50
Bragulat, V., Martinot, M. P., Artiges, É., Frouin, V., Poline, J., & Martinot, J. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.07.002 · Cited by 49
Differences between anhedonic and normally hedonic depressive states
FAWCETT, J. A., Clark, D. C., Scheftner, W. A., & Hedeker, D. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.8.1027 · Cited by 48
Psychiatric applications of bromocriptine therapy.
Marken, P. A., Wells, B., Froemming, J. H., Chu, C. C., & Brown, C. (1990) · PubMed · Cited by 48
Cousins, M. S., & Salamone, J. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00519-7 · Cited by 47
Cross-Cultural Examination of the Tripartite Model With Children: Data From the Barretstown Studies
Kiernan, G., Laurent, J., Joiner, T. E., Catanzaro, S. J., & MacLachlan, M. (2001) · Journal of Personality Assessment · doi:10.1207/s15327752jpa7702_15 · Cited by 46
Psychostimulants in the Treatment of Depression
Orr, K., & Taylor, D. (2007) · CNS Drugs · doi:10.2165/00023210-200721030-00004 · Cited by 46
Bouras, N., & Bridges, P. K. (1982) · Current Medical Research and Opinion · doi:10.1185/03007998209112376 · Cited by 44
A comparative study of bupropion and amitriptyline in depressed outpatients.
MENDELS, J., Amin, M. M., Chouinard, G., Cooper, A. J., Miles, J., Remick, R. A., Saxena, B., Secunda, S. K., & Singh, A. (1983) · PubMed · Cited by 43
Jamerson, B. D., PharmD, Krishnan, K. R. R., MB, ChB, Roberts, J., MS, Krishen, A., MSc, MS, et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4185 · Cited by 42
Emotional and motivational changes after bilateral lesions of the globus pallidus.
Vijayaraghavan, L., Vaidya, J. G., Humphreys, C. T., Beglinger, L. J., & Paradiso, S. (2008) · Neuropsychology · doi:10.1037/0894-4105.22.3.412 · Cited by 42
Palmatier, M. I., Levin, M. E., Mays, K. L., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1666-5 · Cited by 40 · cited 1×
“Similarly, bupropion enhanced responding to a conditioned reinforcer (Palmatier et al., 2009), although a separate study reported a bupropion-induced decrease in responding for sucrose (Reichel et al.”
BackgroundDopamine Receptor Stimulation in the Treatment of Depression: Piribedil (ET-495)
Shopsin, B., & Gershon, S. (2008) · Neuropsychobiology · doi:10.1159/000117615 · Cited by 39
McGinty, V. B., & Grace, A. A. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91162.2008 · Cited by 39
Decoding of dopaminergic mesolimbic activity and depressive behavior
Friedman, A., Yadid, G., Roth‐Deri, I., Dremencov, E., Friedman, Y., Goutkin, S., Kravchinsky, E., Mintz, M., Levi, D., & Overstreet, D. H. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0016-5 · Cited by 38
Does Isotretinoin Cause Depression and Suicide?
Bremner, J. D., & Doraiswamy, P. M. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4196 · Cited by 37
Sensitivity to aversive events in depression: Antecedent, concomitant, or consequent?
Sigmon, S. T., & Nelson‐Gray, R. O. (1992) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/bf00962630 · Cited by 37
Paterson, N. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.009 · Cited by 37
Reichel, C. M., Linkugel, J. D., & Bevins, R. A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.02.002 · Cited by 36
Dopamine agonists in the treatment of non‐motor symptoms of Parkinson’s disease: depression
Lemke, M. R. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02213.x · Cited by 36
Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder
Chiaroni, P., Azorin, J., Dassa, D., Henry, J. M., Giudicelli, S., Malthièry, Y., & Planells, R. (2000) · Psychiatric Genetics · doi:10.1097/00041444-200010010-00008 · Cited by 31
Mello, N. K., Mendelson, J. H., Sholar, M. B., Jaszyna-Gasior, M., Goletiani, N. V., & Siegel, A. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300631 · Cited by 31
McGinty, V. B., & Grace, A. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.028 · Cited by 30
Buckby, J. A., Cotton, S., Cosgrave, E., Killackey, E. J., & Yung, A. R. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-79 · Cited by 27
The role of dopaminergic agents in improving quality of life in major depressive disorder
IsHak, W. W., Davis, M. C., Jeffrey, J. K., Balayan, K., Pechnick, R. N., Bagot, K. S., & Rapaport, M. H. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0076-z · Cited by 25
Diagnosing Major Depressive Disorder Introduction
Zimmerman, M. A., McGlinchey, J. B., Young, D., & Chelminski, I. (2006) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000202235.78441.53 · Cited by 24
CLINICAL PHARMACOLOGY OF β‐ENDORPHIN IN DEPRESSION AND SCHIZOPHRENIA*
Catlin, D. H., Gorelick, D. A., & Gerner, R. H. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb39515.x · Cited by 19
Paroxetine Treatment of Generalized Anxiety Disorder
Sheehan, D. V., Mao, C. G., Mba, Mao, A. C. G., & PharmD (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.7061 · Cited by 18
Amphetamine-induced modification of quinine palatability: Analysis by the taste reactivity test
Parker, L. A., & Leeb, K. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90137-6 · Cited by 16
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
Ninan, P. T., & Beale, M. D. (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.7063 · Cited by 11
Mrazek, D. A. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780195367294.003.0572 · Cited by 3
Flagged first, then by citations
5 of the 357 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Schoenbaum, 2003, A systems approach to orbitofrontal cortex reveal interactions with different learning systems, 146, 19
Cited by
Sorted by citations
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053
“For instance, much is now known about circuits for fear and defense [28], for various aspects of appetitive behavior such as learning to predict reward and moving toward reward [29], and cognitive functions such as working memory [30].”
BackgroundBerridge, K. C., & Kringelbach, M. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.018 · Cited by 1,730
Adult hippocampal neurogenesis buffers stress responses and depressive behaviour
Snyder, J. S., Soumier, A., Brewer, M., Pickel, J., & Cameron, H. A. (2011) · Nature · doi:10.1038/nature10287 · Cited by 1,473
The mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418
Cuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377
Metadata
- Authors
- Treadway, M. T., & Zald, D. H.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Treadway, Michael T.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 35
- Issue
- 3
- Pages
- 537-555
- ISSN
- 0149-7634 (ISSN-L)
- PMC
- PMC3005986
- OpenAlex
- W2049882268
- Cited by
- 1,579
- References
- 357
- Citations by year
- 2026: 154 · 2025: 141 · 2024: 107 · 2023: 120 · 2022: 93 · 2021: 109 · 2020: 158 · 2019: 107 · 2018: 118 · 2017: 95 · 2016: 93 · 2015: 92 · 2014: 74 · 2013: 51 · 2012: 48
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (F31MH087015)
- National Institute on Drug Abuse (R01DA019670)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- anhedonia, major depressive disorder, dopamine, reward motivation, translational neuroscience
- MeSH terms
- Animals, Depression, Dopamine, Humans, Motivation, Neurosciences, Reward, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
